English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 848726      Online Users : 1277
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    報告 [0/1]
    專利 [0/11]
    期刊論文 [193/194]
    會議論文/會議摘要 [41/48]

    Community Statistics


    近3年內發表的文件:0(0.00%)
    含全文筆數:234(92.13%)

    文件下載次數統計
    下載大於0次:234(100.00%)
    下載大於100次:234(100.00%)
    檔案下載總次數:146303(2.73%)

    最後更新時間: 2024-11-28 10:27

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 201-225 of 254. (11 Page(s) Totally)
    << < 2 3 4 5 6 7 8 9 10 11 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2007-07-31 Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil British Journal of Cancer. 2007 Jul;97(3):334-344.
    2007-07 A novel oral indoline-sulfonamide derivative, J30, exhibits potent activity against human cancer cells both in in vitro and in vivo through disruption of microtubule Drugs of the Future. 2007 Jul;32(Suppl. A):35-36.
    2007-03-01 Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036 Biochemical Pharmacology. 2007 Mar;73(5):610-619.
    2007-02-26 Cytotoxic and novel skeleton compounds from the heartwood of Chamaecyparis obtusa var. formosana Tetrahedron Letters. 2007 Feb;48(9):1567-1569.
    2007-02-17 Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy Journal of Cancer Molecules. 2007 Feb 17;3(1):5-14.
    2007-01 D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation Molecular Cancer Therapeutics. 2007 Jan;6(1):193-202.
    2006-12 Statistical quality control process for traditional Chinese medicine Journal of Biopharmaceutical Statistics. 2006 Dec;16(6):861-874.
    2006-11-27 C-35 terpenoids from the bark of Calocedrus macrolepis var. formosana with activity against human cancer cell lines Journal of Natural Products. 2006 Nov;69(11):1611-1613.
    2006-11-16 7-aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents Journal of Medicinal Chemistry. 2006 Nov;49(23):6656-6659.
    2006-11 Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.
    2006-11 Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity EJC Supplements. 2006 Nov;4(12):59.
    2006-11 D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation EJC Supplements. 2006 Nov;4(12):92.
    2006-11 Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells EJC Supplements. 2006 Nov;4(12):155.
    2006-10-19 2-amino and 2 '-aminocombretastatin derivatives as potent antimitotic agents Journal of Medicinal Chemistry. 2006 Oct;49(21):6412-6415.
    2006-10 Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents ChemMedChem. 2006 Oct;1(10):1106-1118.
    2006-09-25 Synthesis of new camptothecin analogues with the E-lactone ring replaced by alpha,beta-cyclohexenone European Journal of Organic Chemistry. 2006 Sep(19):4490-4499.
    2006-07-28 In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells Biochemical Pharmacology. 2006 Jul;72(3):308-319.
    2006-05 Antitubulin agents for the treatment of cancer - a medicinal chemistry update Expert Opinion on Therapeutic Patents. 2006 May;16(5):647-691.
    2006-05 Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879.
    2006-03 Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer Journal of Gastroenterology and Hepatology. 2006 Mar;21(3):531-536.
    2006-02 DNA repair enzyme, O-6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors Journal of Pharmacology and Experimental Therapeutics. 2006 Feb;316(2):946-954.
    2006-01 Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma Head and Neck. 2006 Jan;28(1):74-80.
    2005-12-01 Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives Bioorganic and Medicinal Chemistry. 2005 Dec;13(23):6513-6520.
    2005-12 Pulmonary embolism after transcatheter arterial chemoembolization European Journal of Cancer Care. 2005 Dec;14(5):440-442.
    2005-12 Induction of cell death by a novel selenophene derivative, D-501036, in human cancer cell lines Clinical Cancer Research. 2005 Dec;11(24):9101S.

    Showing items 201-225 of 254. (11 Page(s) Totally)
    << < 2 3 4 5 6 7 8 9 10 11 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback